LigaChem Biosciences Inc.
Research LigaChem Biosciences Inc. (141080.KQ) on Bullrun: market cap KRW 2.52T. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker141080.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 2.52T
- Financial periodQ2 2026
- RevenueKRW 5.53B
- Net income-KRW 71.20B
- Free cash flow-KRW 61.24B
- Gross margin57.2%
Valuation Snapshot
latest market cap is KRW 2.52T.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 2.52T | n/a | n/a | n/a |
Dividend history
About LigaChem Biosciences Inc.
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is LigaChem Biosciences Inc.'s market cap?
LigaChem Biosciences Inc.'s market capitalization is KRW 2.52T.
What does LigaChem Biosciences Inc. do?
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc.